Health Care [ 12/12 ] | Life Sciences Tools & Services [ 71/74 ]
NASDAQ | Common Stock
Fortrea Holdings Inc., a contract research organization, primarily engages in the provision of biopharmaceutical product and medical device development services worldwide.
The company operates through two segments: Clinical Services and Enabling Services.
The Clinical Services segment provides across the clinical pharmacology and clinical development spectrum.
The Enabling Services segment provides patient access and clinical trial technology solutions to customers that streamline complex randomization and optimize the trial drug supply process.
The company offers delivery models that include full service, functional service provider, and hybrid service structures.
It also offers phase I-IV clinical trial management, differentiated technology enabled trial solutions, and post approval services, as well as consulting services.
The company serves pharmaceutical, biotechnology, and medical device organizations.
Fortrea Holdings Inc. was incorporated in 2023 and is headquartered in Durham, North Carolina.
| Reported date | EPSChange YoY | EstimateSurprise |
|---|---|---|
| Aug 12, 24 | -0.03 Decreased by -105.77% | 0.08 Decreased by -137.50% |
| May 13, 24 | -0.04 Decreased by -108.81% | 0.01 Decreased by -500.00% |
| Mar 11, 24 | 0.19 | 0.24 Decreased by -20.83% |
| Nov 13, 23 | -0.15 | 0.16 Decreased by -193.75% |
| Aug 24, 23 | 0.52 | - |
| May 31, 23 | 0.45 | - |
| Fiscal ending date | RevenueChange YoY | IncomeChange YoY | ProfitChange YoY |
|---|---|---|---|
| Sep 30, 24 | 674.90 M Decreased by -13.07% | -2.30 M Increased by +82.44% | Decreased by -0.34% Increased by +79.80% |
| Jun 30, 24 | 662.40 M Decreased by -16.47% | -115.20 M Decreased by -474.03% | Decreased by -17.39% Decreased by -547.77% |
| Mar 31, 24 | 662.10 M Decreased by -13.36% | -101.00 M Decreased by -770.69% | Decreased by -15.25% Decreased by -904.96% |
| Dec 31, 23 | 775.40 M Increased by +1.80% | -36.00 M Increased by +64.39% | Decreased by -4.64% Increased by +65.02% |
| Sep 30, 23 | 776.40 M Increased by +1.85% | -13.10 M Decreased by -121.62% | Decreased by -1.69% Decreased by -121.22% |
| Jun 30, 23 | 793.00 M Decreased by -0.01% | 30.80 M Decreased by -53.61% | Increased by +3.88% Decreased by -53.61% |
| Mar 31, 23 | 764.20 M Decreased by -1.90% | -11.60 M Decreased by -135.69% | Decreased by -1.52% Decreased by -136.38% |
| Dec 31, 22 | 761.70 M - | -101.10 M - | Decreased by -13.27% - |